Agency says application rejected due to lack of ‘adequate and well controlled’ trial, but experts say ‘they’re just coming up with reasons’

A senior US Food and Drug Administration (FDA) official says Moderna’s clinical trial on a new, potentially more effective flu vaccine was a “brazen failure” and that the FDA is now calling it into question.

The FDA unexpectedly refused to consider Moderna’s application for a flu shot based on messenger RNA (mRNA) technology in a decision that experts say is already having a chilling effect on vaccine development.

Officials say the issue is the design of the study, in which control group participants over the age of 65 should have received a high-dose flu shot instead of a standard flu shot.

Outside experts say the reasons seem to go deeper. “It’s all pretext and obfuscation when the real agenda is rejecting conventional science and serving a predetermined anti-vaccine agenda,” said Richard Hughes IV, a partner with Epstein Becker Green and law professor at George Washington University.

  • BarneyPiccolo@lemmy.today
    link
    fedilink
    arrow-up
    6
    ·
    9 days ago

    When we take our country back, we should force these rich hyenas to fund the repairs out of their personal fortunes. Whatever is left, gets confiscated to fund Universal Health Care and UBI. They won’t need it, they’ll all be in prison, if they’re lucky.